Back
Viridian Therapeutics, Inc. Stock Predictions
Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.
Stop trusting exchanges. Learn how to access Native Markets where YOU control your assets
Buy
59
VRDN
Viridian Therapeutics, Inc.
Last Price:
$33.25
Seasonality Move:
-12.78%
7 Day Trial
ALL ACCESS PASS
$
7
99.6% Win Rate Across 508 Picks (Third-Party Audited)
See how Decentralized Masters' system identifies 10x-100x opportunities before Coinbase. Watch free training.Viridian Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Viridian Therapeutics, Inc. has on average historically risen by 2.3% based on the past 11 years of stock performance.
-
Viridian Therapeutics, Inc. has risen higher in 4 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 36.36%
-
Is Viridian Therapeutics, Inc. Stock Undervalued?The current Viridian Therapeutics, Inc. [VRDN] share price is $32.17. The Score for VRDN is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
VRDN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Viridian Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Viridian Therapeutics, Inc. has on average historically risen by 2.3% based on the past 11 years of stock performance.
Viridian Therapeutics, Inc. Stock Rating
Buy
59
Viridian Therapeutics, Inc. (VRDN)
is a Buy
Is Viridian Therapeutics, Inc. overpriced?
-
Viridian Therapeutics, Inc. has risen higher in 4 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 36.36%
Viridian Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
viridiantherapeutics.com
52-Week Data
52-Week High:
34.29
52-Week Low:
9.90
Prediction Charts
Market Cap:
3.1B
Price in USD:
32.17
Volume:
2.1M
Beta:
1.24
Technical Analysis
SMA50:
31.28
SMA100:
26.29
SMA200:
20.73
52-Wk Change:
75.31%
Stock Predictions
-
Is Viridian Therapeutics, Inc. stock public?Yes, Viridian Therapeutics, Inc. is a publicly traded company.
-
What is the Viridian Therapeutics, Inc. stock quote today?The Viridian Therapeutics, Inc. stock price is 32.17 USD today.
-
How to buy Viridian Therapeutics, Inc. stock online?You can buy Viridian Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-2 | 30.80 | 30.68 | 31.54 | 30.35 |
| Jan-5 | 30.61 | 30.20 | 30.72 | 28.96 |
| Jan-6 | 29.69 | 30.72 | 31.00 | 29.69 |
| Jan-7 | 31.47 | 30.57 | 31.47 | 29.90 |
| Jan-8 | 30.17 | 30.33 | 30.68 | 29.63 |
| Jan-9 | 30.87 | 31.75 | 31.89 | 30.60 |
| Jan-12 | 31.83 | 32.57 | 32.70 | 31.16 |
| Jan-13 | 32.36 | 31.99 | 32.36 | 31.39 |
| Jan-14 | 31.99 | 33.78 | 34.29 | 31.69 |
| Jan-15 | 33.89 | 33.03 | 33.99 | 32.89 |
| Jan-16 | 33.08 | 33.26 | 33.82 | 32.50 |
| Jan-20 | 32.48 | 32.64 | 32.98 | 32.13 |
| Jan-21 | 32.33 | 32.29 | 32.90 | 31.94 |
| Jan-22 | 32.40 | 32.17 | 32.66 | 31.26 |
Viridian Therapeutics, Inc. Earnings
Viridian Therapeutics, Inc. Earnings Report: Per Share Viridian Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Viridian Therapeutics, Inc. Forecast Revenue Growth
Viridian Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Viridian Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $1.85 per share.
* Viridian Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.